Quinazolin-4(3H)-one derivatives as anticoccidial agents

ABSTRACT

Variously substituted trans-3-[3-(3-hydroxypiperid-2-yl)-2-oxopropyl]quinazolin-4-(3H)-ones, a method of controlling or preventing coccidiosis in poultry therewith, intermediates therefor, and a process for the preparation of certain intermediates therefor.

BACKGROUND OF THE INVENTION

The present invention is concerned with certaintrans-3-[3-(3-hydroxy-2-piperidyl)-2-oxopropyl]quinazolin-4(3H)-onederivatives, a method of using same as anticoccidial agents,intermediates therefor, and a process for certain intermediatestherefor.

Coccidiosis, a poultry disease, is caused by several species ofprotozoan parasites of the genus Eimeria, such as E. acervulina and E.tenella. In particular, E. tenella is the causative agent of a severeand often fatal infection of the ceca of chickens which is manifested byextensive hemorrhage, accumulation of blood in the cecum (a pouchbetween the large and small intestines) and the passage of blood in thedroppings. Essentially, coccidiosis is an intestinal disease which isdisseminated by birds picking up the infectious organism in droppings oncontaminated litter or ground. By damaging the intestinal wall, the hostanimal is unable to utilize its food, goes off its feed, and inuntreated cases the disease terminates in either the death of the animalor the survival of unthrifty birds known commonly as "culls."

Several classes of compounds have been reported to be useful asanticoccidial agents. Among these are various 6-azauracil derivatives(Miller, U.S. Pat. No. 4,239,888; summarizing several additionalclasses);trans-3-[3-(3-hydroxy-2-piperidyl)-2-oxopropyl]-4(3H)-quinazolinone[febrifugine; The Merck Index, Tenth Edition, monograph No. 3881); andtrans-7-bromo-6-chloro-3-[3-(3-hydroxy-2-piperidyl)-2-oxopropyl]-4-(3H)-quinazolinone(halofuginone; The Merck Index, Tenth Edition, monograph No. 4479). Suchanticoccidial compounds are more broadly defined by Waletzky et al.,U.S. Pat. No. 3,320,124 (Re. 26,833); and Jolly et al., U.S. Pat. No.4,252,947. European Patent Application 98589 broadly disclosesstructurally related hydrazine derivatives oftrans-3-[3-(3-hydroxy-2-piperidyl)-2-oxopropyl]quinazolin-4(3H)-ones asanticoccidial agents.

Structurally related compounds are also reported to be useful incombatting theileriosis in cattle (Schein, U.S. Pat. No. 4,340,596).Although not in any manner specifically disclosed, the broad genus ofSchein can be selectively chosen so as to define instant6-trifluoromethyl-3-[3-(3-hydroxypiperid-2-yl)-2-oxopropyl]quinazolin-4(3H)-one.The present anticoccidial activity of that novel species is mostsurprising in view of the fact that the isomeric 7-trifluoromethylanalog (also defined by Schein's broad genus) is lacking in instantanticoccidial activity.

Structurally related compounds, including broad generic disclosure of3-[3-(3-hydroxy-2-piperidyl)-2-oxopropyl]quinazolin-4(3H)-onessubstituted on the aromatic ring with halogen, trifluoromethyl, loweralkylthio, methoxy, phenoxy and benzyloxy groups, have also beendisclosed as antimalarial agents by Baker et al., U.S. Pat. No.2,694,711; see also Baker et al., U.S. Pat. Nos. 2,651,632 and 2,796,417for compounds related to present intermediates. Although not in anymanner specifically disclosed, a number of the instantly claimedcompounds can be defined by said genera, once having knowledge of thepresent invention. While Baker et al. ('711) specifically disclose the5-trifluoromethyl analog (isomeric with the present 6-trifluoromethylanalog), it is noteworthy that that compound is lacking in presentanticoccidial activity.

SUMMARY OF THE INVENTION

Although above febrifugine and halofuginone are useful as anticoccidialagents, we have determined that a number of related compounds (forexample,trans-3-[3-(3-hydroxy-2-piperidyl)-2-oxopropyl]quinazolin-4(3H)-onessubstituted on the aromatic ring as follows:

6-phenoxy-7-chloro,

6-(4-hydroxyphenoxy)-7-chloro,

7-(4-bromophenoxy),

7-(4-bromophenoxy)-6-chloro,

5-methylthio,

6-(4-fluorobenzylthio)-7-chloro,

7-cyano,

5-trifluoromethyl,

7-trifluoromethyl, or

8-trifluoromethyl)

are lacking in useful anticoccidial activity in poultry. In spite ofsuch lack of activity, we have surprisingly discovered a number ofcompounds, very closely related in structure, which are highly active asanticoccidial agents, as determined by their activity against E.tenella.

Thus the present invention is directed to anticoccidial compounds havingthe formula ##STR1## wherein X is fluoro, chloro, bromo or iodosubstituted at the 6- or 7-position;

R is (C₁ -C₄)alkylthio;

X¹ is hydrogen or fluoro, chloro, bromo, iodo or methoxy substitutedeither at the 7- or at the 8-position; and

R¹ is cyano, trifluoromethyl, (C₁ -C₄)alkylthio, 4-picolylthio,3,5-dichlorophenoxy, ##STR2## where Y¹ is hydrogen, fluoro, chloro,bromo or phenoxy; and Y² is chloro or bromo; with the proviso that Y¹ isother than hydrogen when X¹ is other than hydrogen,

or a pharmaceutically-acceptable acid addition salt thereof.

The compounds of the present invention are racemic (not opticallyactive). The heavy and dotted bonds in the various formulae thereforeindicate relative, not absolute, stereochemistry.

Pharmaceutically-acceptable acid addition salts include, but are notrestricted to, those with HCl, HBr, H₂ SO₄, CH₃ SO₃ H, p-CH₃ C₆ H₄ SO₃H, lactic acid, fumaric acid, citric acid and the like.

Most preferred compounds, because of their ease of preparation and highactivity, are of the formula (I), particularly those compounds whereinR¹ is methylthio and X¹ is hydrogen, 7-fluoro, 7-chloro or 7-bromo.

The present invention also encompasses a method of controlling orpreventing coccidiosis in poultry which comprises administering to saidpoultry an anticoccidially effective amount of a compound of the formula(I) in drinking water or in nutritionally-balanced feed.

Also claimed are valuable intermediates of the formula: ##STR3## whereinX, R, X¹ and R¹ are as defined above;

R² is hydrogen, acetyl or (C₁ -C₄)alkyl; and

R³ is hydrogen or COOR⁴ ; where R⁴ is allyl or (C₁ -C₄)alkyl;

with the provisos that at least one of R² and R³ is other than hydrogen,and that R³ is hydrogen when R² is acetyl; and ##STR4## wherein X, R, X¹and R¹ are as defined above.

In addition, we claim a process for preparing a compound of the formula##STR5## wherein R is (C₁ -C₄)alkylthio;

R⁵ and R⁶ are each independently (C₁ -C₄)alkyl;

X is fluoro, chloro, bromo or iodo;

R⁷ is (C₁ -C₄)alkyl, 4-picolyl or ##STR6## Y² is chloro or bromo; and X³is fluoro, chloro, bromo or iodo substituted at the 3- or 4-position;

which comprises:

(a) reaction of a compound of the formula ##STR7## with at least 2 molarequivalents of NH₄ SCN in the presence of substantially 1 molarequivalent of Br₂ in a reaction inert solvent comprising a (C₁-C₄)alkanoic acid;

(b) solvolyzing the resulting compound having the formula ##STR8## withat least one equivalent of a nucleophile in a reaction inert solventcomprising water or a (C₁ -C₄)-alkanol; and

(c) reacting the resulting thiophenoxide, having the formula ##STR9##with a compound of the formula

    R.sup.6 X.sup.4

or

    R.sup.7 X.sup.4

wherein X⁴ is a nucleophilically displaceable group, in the same oranother reaction inert solvent to form a compound of the formula (VII)or (VIII).

The preferred nucleophile is an alkali metal alkoxide, particularlymethoxide. The preferred solvent comprises methanol.

DETAILED DESCRIPTION OF THE INVENTION

The compounds of the present invention are readily prepared bynucleophilic displacement: ##STR10## where in (III), (IV) and (IX), R²and R⁴ are both defined as above but R² is other than hydrogen, and Y³is a nucleophilically displaceable group such as chloro, bromo, iodo ormesylate; followed by solvolytic or hydrolytic removal of the groups R²and COOR⁴. Because of their ready availability, preferred compounds ofthe formula (IX) have Y³ as bromo, R² as methyl and R⁴ as methyl orallyl.

The nucleophilic displacement reaction between compounds of the formulae(V) or (VI) and (IX) in all cases involves replacement of the leavinggroup, Y³, with a relatively non-nucleophilic nitrogen. For this reasonit is essential to employ a base of sufficient strength to form theanion of the compound (V) or (VI) in an amount at least sufficient toneutralize all of the acid (HY³) coproduced in the reaction. Alkalimetal (C₁ -C₄)alkoxides are well suited for this purpose. The reactionis generally carried out in a reaction inert solvent such as a loweralkanol, acetonitrile or dimethylformamide. The solvent should be lessacidic than the compound (V) or (VI), so as to facilitate formation ofthe required anion. Sodium methoxide as base in methanol as solventrepresent conditions particularly well suited for the present reaction.The temperature employed for this reaction is best kept below 40° C.(e.g., temperatures in the range of 0°-30° C. are fully satisfactory).It should be high enough to provide a reasonable rate, but not so highas to lead to undue decomposition. As is well known in the art, ratewill vary with the nature of the leaving group (e.g. rate: I>Br>Cl), thespecific structure of the compound (V) or (VI), the concentration ofreagents and the solvent. The reaction time should be such that thereaction is nearly complete [e.g. >95% conversion when equivalentamounts of the compounds (V) or (VI) and (IX) are employed] to maximizeyields [e.g. reaction times 1 hour to several hours at ambienttemperature are well suited when Y³ is bromo, the base is sodiummethoxide, the solvent is methanol, and the concentration of compound(IX) is in the range 3-10% (w/v)]. Of course, complete reaction can befacilitated by use of an excess of one of the reagents, e.g. an excessof the compound (V) or (VI) when it is the more readily available of thetwo reagents.

The present nucleophilic displacement reactions produce compounds of theabove formula (III) or (IV) wherein R² is (C₁ -C₄)alkyl and R³ is COOR⁴(where R⁴ is defined above). The groups R² and COOR⁴ are readilyremoved, stepwise or in a single step, to produce the desired compoundsof the formula (I) or (II). Thus the (C₁ -C₄)alkyl ether group isconveniently and selectively removed by the action of BBr₃ in a reactioninert solvent at a temperature ranging from -70° to 0° C. Methylenechloride as solvent is particularly well suited for this purpose, sincesolutions of BBr₃ therein are commercially available. This methodproduces intermediate compounds of the formula (III) or (IV) wherein R²is hydrogen. The COOR⁴ group is then conveniently removed from thelatter intermediates by briefly heating with concentrated aqueous HBr,e.g. heating in 48% HBr for 2 to 10 minutes at 80°-150° C.; heating in6N HCl at or near reflux temperature; or concentrated HBr in glacialacetic acid at 0°-30° C. The latter process generally produces thecompound (III) or (IV) wherein R³ is hydrogen and R² is generallyacetyl. The latter is removed by mild hydrolysis, e.g., 6N HCl at10°-30° C.

Alternatively, the groups R² and R³ are removed in reverse order, using33% HBr in acetic acid at 10°-30° C. to remove the group R³, followed byheating at or near reflux in 48% aqueous HBr to remove the group R² ; orboth groups R² and R³ are concurrently removed by use of the latter 48%HBr conditions.

The acid addition salts of the compounds of the present invention, ifnot directly isolated, for example, as the hydrobromide salt directlyfrom the reaction mixture, are obtained by contacting the free base withat least one equivalent of the appropriate acid in a reaction inertsolvent. Those salts which do not precipitate directly are isolated byconcentration and/or the addition of a non-solvent. Conversely, the freebase form is conveniently formed from an acid addition salt byneutralization of the latter in water with recovery of the free base byfiltration or extraction into a water immiscible organic solvent.

The required starting compounds of the formula (V) or (VI) are generallyprepared by methods known in the chemical art. Some of the requiredstarting 2-aminobenzoic acids or esters required in the synthesis of thecompounds (V) and (VI) are known, or accesible by known methods. Others,in particular those of the above formula (VII) or (VIII) are now morepractically accessible via the presently discovered, improved processfor their preparation, as summarized above and as detailed in specificpreparations below.

The cocciodiostatic activity of the compounds of the present inventionis demonstrated as follows. Groups of chicks (e.g. groups of fiveten-day old SPF white Leghorn cockerels) are fed a nutritionallycomplete basal ration into which the test compound is incorporated atvarious concentrations. The basal ration is generally a commercial chickstarter (e.g. Agway Commercial Chick Starter, available from the AgwayFeed Co., Franklin, Conn.), and is presented ad libitum to the chicks 24hours before infection and continuously thereafter throughout the courseof the tests.

Twenty-four hours after initiation of the medication the chicks areinoculated orally with 100,000 sporulated oocysts (Eimeria tenella) andthe average weight per bird per group determined. In addition, a groupof six chicks is fed the basal ration which contains none of the testcompound (infected, untreated controls). A further group of six chicksserves as uninfected, untreated controls. The chicks are examined on thefifth and sixth day post-infection for signs of hemorrhage. On the sixthday post-infection, the average body weight per bird per group isdetermined, the birds necropsied, the cecum examined macroscopically,and a pathology index (average degree of infection [A.D.I.]) determined.Chicks which die prior to the fifth day post-infection are considered astoxic deaths. Those which die five days post-infection or later areconsidered as deaths due to disease. The degree of pathologicinvolvement at necropsy is expressed as the average degree based on thefollowing scheme: 0=no cecal lesions; 1=slight lesions; 2=moderatelesions; 3=severe lesions; 4=death.

The efficacy of the test compound, at a given level in feed, is judgedby comparison of the pathologic index with that of the unmedicatedinfected controls, expressed as the ratio: ##EQU1## Against E. tenella,the compounds of the present invention generally show a value of saidratio no higher than 0.6 at a feed concentration no higher than 25p.p.m. The typical range of results obtained with the compounds of thepresent invention are illustrated as follows:

    ______________________________________                                                             Ratios at Feed                                           Compound             Concentration (ppm)                                      (I)/(II)                                                                             X/X.sup.1                                                                             R/R.sup.1     25   12.5 6.25 3.12                              ______________________________________                                        (II)   7-Cl    6-(4-FC.sub.6 H.sub.5 O)                                                                    0.0  0.0  0.33 0.67                              (I)    6-Cl    8-SCH.sub.3   0.0  0.32 0.73 0.95                              (II)   7-Br    6-SC.sub.2 H.sub.5                                                                          0.10 0.33 1.0  1.0                               (II)   H       6-(3,5-Cl.sub.2 C.sub.6 H.sub.3 O)                                                          0.10 0.95 1.27 1.05                              ______________________________________                                    

It will be noted that a ratio of 0.0 indicates 100% control of pathologydue to the infection at the indicated feed concentration.

The compounds of this invention are orally administered to poultry in asuitable carrier. Conveniently, the medication is simply carried in thedrinking water or in the poultry feed, so that a therapeutic dosage ofthe agent is ingested with the daily water or poultry ration. The agentcan be directly metered into drinking water, preferably in the form of aliquid, watersoluble concentrate (such as aqueous solution of a watersoluble salt) or added directly to the feed, as such, or in the form ofa premix or concentrate. A premix or concentrate of therapeutic agent ina carrier is commonly employed for the inclusion of the agent in thefeed. Suitable carriers are liquid or solid, as desired, such as water,various meals (for example, soybean oil meal, linseed oil meal, corncobmeal), and mineral mixes such as are commonly employed in poultry feeds.A particularly effective carrier is the poultry feed itself; that is, asmall portion of poultry feed. The carrier facilitates uniformdistribution of the active materials in the finished feed with which thepremix is blended. This is important because only small proportions ofthe present potent agents are required. It is important that thecompound be thoroughly blended into the premix and, subsequently, thefeed. In this respect, the agent may be dispersed or dissolved in asuitable oily vehicle such as soybean oil, corn oil, cottonseed oil, andthe like, or in a volatile organic solvent and then blended with thecarrier. It will be appreciated that the proportions of active materialin the concentrate are capable of wide variation since the amount ofagent in the finished feed may be adjusted by blending the appropriateproportion of premix with the feed to obtain a desired level oftherapeutic agent.

High potency concentrates may be blended by the feed manufacturer withproteinaceous carrier such as soybean oil meal and other meals, asdescribed above, to produce concentrated supplements which are suitablefor direct feeding to poultry. In such instances, the poultry arepermitted to consume the usual diet. Alternatively, such concentratedsupplements may be added directly to the poultry feed to produce anutritionally balanced, finished feed containing a therapeuticallyeffective level of one or more of the compounds of this invention. Themixtures are thoroughly blended by standard procedures, such as in atwin shell blender, to ensure homogeneity.

It will, of course, be obvious to those skilled in the art that the uselevels of the compounds described herein will vary under differentcircumstances Continuous low-level medication, during the growingperiod; that is, during the first 6 to 12 weeks for chickens, is aneffective prophylatic measure In the treatment of establishedinfections, higher levels may be necessary to overcome the infection.The use level in feed will generally be in the range of 3 to 100 ppm.When administered in drinking water, the level which will be that whichwill provide the same daily dose of medication, i.e. 3 to 100 ppm,factored by the weight ratio of the average daily consumption of feed tothe average daily consumption of water.

The present invention is illustrated by the following examples However,it should be understood that the invention is not limited to thespecific details of these examples.

EXAMPLE 1 Allyltrans-2-[3-(7-chloro-6-(4-chlorophenoxy)-quinazolin-4(3H)-on-3-yl)-2-oxopropyl]-3-methoxypiperidine-1-carboxylate[Formula (IV) with X¹ =7-chloro, R¹ =4-chlorophenoxy, R² =methyl and R⁴=allyloxycarbonyl]

Under a nitrogen atmosphere in a flame-dried flask at room temperatureand with magnetic stirring, 0.921 g (0.003 mol) of7-chloro-6-(4-chlorophenoxy)quinazolin-4(3H)-one was slurried in 3.0 mlof 1.1N sodium methoxide. After 15 minutes, 1.00 g (0.003 mol) of allyltrans-2-(3-bromo-2-oxopropyl)-3-methoxy-1-piperidinecarboxylate in 10 mlof methanol was added dropwise. After 2 hours, the reaction mixture wasevaporated under reduced pressure, and the residue treated with water.The aqueous solution was extracted three times with 75 ml ofdichloromethane. The combined extracts were dried over anhydrousmagnesium sulfate, filtered, and evaporated to afford the titlecompound: yield 1.28 g (76%); m.p. 138°-141° C. H-NMR(CDCl₃) 1.3 to 1.9(m, 4H), 2.6-3.4 (m, 6H), 3.3 (s, 3H), 4.9 (s, 2H), 4.5-6.2 (m, 5H), 7.1(q, 4H), 7.6 (s, 1H), 7.8 (d, 2H) ppm.

By the same method, other suitably substituted6-phenoxyquinazolin-4(3H)-ones were converted to allyl trans-2-[3-(7-X¹substituted)-6-(Y¹ substitutedphenoxy)-quinazolin-4(3H)-on-3-yl]-2-oxopropyl]-3-methoxypiperidine-1-carboxylatesas follows:

    ______________________________________                                        Y.sup.1   X.sup.1   m.p. (°C.)                                                                       yield (%)                                       ______________________________________                                        H         H         122-125   43                                              4-Br      H          88-170   57                                              4-Cl      H         foam.sup.(a)                                                                            76                                              3-Cl      H         oil.sup.(b)                                                                             83                                              2-Cl      H         foam.sup.(b)                                                                            89                                              3,5-di-Cl H         foam.sup.(b)                                                                            47                                              4-OPh     H         110-152   66                                              4-Br      Cl        142-144   82                                              4-Cl      Cl        138-141   76                                              4-F       Cl        .sup.(b)  54                                              4-Cl      Br        145-148   67                                              3-Cl      Cl        foam.sup.(b)                                                                            62                                              3-Br      Cl        .sup.(b)  67                                              ______________________________________                                         .sup.(a)1 H--NMR(CDCl.sub.3)delta: 1.4-2.0 (m, 4H), 2.6-3.6 (m, 6H), 3.3      (s, 3H), 5.2 (s, 2H), 4.5-6.2 (m, 5H), 6.9-7.9 (m, 8H) ppm;                   .sup.(b)1 H--NMR(CDCl.sub.3), like that of the 4chlorophenoxy analog, is      consistent with the assigned structure.                                  

EXAMPLE 2trans-7-Chloro-6-(4-chlorophenoxy)-3-[3-(3-methoxypiperid-2-yl)-2-oxopropyl]-quinazolin-4(3H)-oneDihydrobromide [Compound (IV) with X¹ =chloro, R¹ =4-chlorophenoxy, R²=methyl and R³ =hydrogen]

A solution of 1.15 g (0.002 mol) of the title product of the precedingExample in 50 ml of 33% hydrobromic acid in acetic acid was stirred atroom temperature for 45 minutes. The solvent was evaporated underreduced pressure and the residue triturated with ethanol. The resultingsuspension was filtered to afford the present title compound as a whitesolid: m.p. 229°-231° C.; yield 0.897 g (68%).

By the same method, the other compounds of the preceding Example wereconverted to the corresponding dihydrobromide salts of trans-7-(X¹substituted)-6-(Y¹ -substitutedphenoxy)-3-[3-(3-methoxypiperidin-2-yl)-2-oxopropyl]quinazolin-4(3H)-onesas follows:

    ______________________________________                                        Y.sup.1   X.sup.1   m.p. (°C.)                                                                       yield (%)                                       ______________________________________                                        H         H         215-218   62                                              4-Br      H         218-220   35                                              4-Cl      H         --*       26                                              3-Cl      H         212-219   42                                              2-Cl      H         233-235   57                                              3,5-di-Cl H         240-243   59                                              4-OPh     H         225-227   82                                              4-Br      Cl        224-227   65                                              4-Cl      Cl        229-231   68                                              4-F       Cl        247-248   68                                              4-Cl      Br        230-232   50                                              3-Cl      Cl        235-238   46                                              3-Br      Cl        221-222   53                                              ______________________________________                                         *.sup.1 H--NMR(DMSOd.sub.6)delta: 1.3-2.1 (m, 4H), 2.9-3.6 (m, 6H), 3.4       (s, 3H), 5.2 (s, 2H), 7.0-7.8 (m, 7H), 8.4 (s, 1H).                      

EXAMPLE 3trans-7-Chloro-6-(4-chlorophenoxy)-3-[3-(3-hydroxypiperid-2-yl)-2-oxopropyl]-quinazolin-4(3H)-oneDihydrobromide [Formula (II) with X¹ =7-chloro and R¹ =4-chlorophenoxy]

A solution of 0.80 g (0.0012 mol) of the title product from thepreceding Example in 40 ml of 48% hydrobromic acid was heated at refluxfor 15 minutes. The reaction mixture was cooled to room temperature andevaporated to an oil under reduced pressure. The residue was treatedwith several ml of ethanol and the resulting solution was evaporated.This operation was repeated several times. Finally, the residue wastaken up in hot ethanol and the product crystallized upon cooling toroom temperature. Filtration gave the title compound: m.p. 185°-188° C.;yield 0.674 g (86%).

Analysis calculated for C₂₂ H₂₁ Cl₂ N₃ O₄.2HBr.1/2H₂ O: C, 41.73; H,3.82; N, 6.64%. Found: C, 41.74; H, 3.80, N, 6.75%.

By the same method the other products of the preceding Example wereconverted to corresponding dihydrobromide salts of trans-7-(X¹substituted)-6-(Y¹ substitutedphenoxy-3-[3-(3-hydroxypiperid-2-yl)-2-oxo-propylquinazolin-4(3H)-onesas follows:

    ______________________________________                                        Y.sup.1   X.sup.1   m.p. (°C.)                                                                       yield (%)                                       ______________________________________                                        H         H         223-224   58                                              4-Br      H         226-227   53                                              4-Cl      H         foam.sup.(a)                                                                            35                                              3-Cl      H         224-226   79                                              2-Cl      H         238-239   85                                              3,5-di-Cl H         foam.sup.(b)                                                                            43                                              4-OPh     H         237-239   69                                              4-Br      Cl        186-187   94                                              4-Cl      Cl        185-188   86                                              4-F       Cl        39-240    52                                              4-Cl      Br        238-239   88                                              3-Cl      Cl        247-248   82                                              3-Br      Cl        250-251   82                                              ______________________________________                                         .sup.(a)13 C--NMR(DMSOd.sub.6): 20.307, 30.817, 43.155, 54.537, 56.379,       66.768, 112.46, 121.185, 122.213, 126.232, 128.227, 129.336, 130.123,         143.252, 147.019, 154.575, 155.508, 159.215, 200.448.                         .sup.(b)1 H--NMR(DMSOd.sub.6): 1.5-2.1 (m, 4H), 2.9-3.8 (m, 6H), 5.2 (s,      2H), 7.2-7.9 (m, 6H), 8.4 (s, 1H).                                       

EXAMPLE 4 Allyltrans-2-[3-(7-Bromo-6-methylthioquinazolin-4(3H)-on-3-yl)-2-oxopropyl]-3-methoxy-1-piperidinecarboxylate

Under a nitrogen atmosphere in a flame dried flask at room temperatureand with magnetic stirring, a suspension of 0.43 g (0.00136 mol) of7-bromo-6-methylthioquinazolin-4(3H)-one formic acid salt in 5 ml ofmethanol was treated with two equivalents of sodium methoxide inmethanol (approximately 1N). After 15 minutes 0.53 g (0.0016 mol) ofallyl trans-2-(3-bromo-2-oxopropyl)-3-methoxy-1-piperidinecarboxylatewas added in one portion. After being stirred for an hour, the reactionmixture was evaporated under reduced pressure, and the residue was takenup in about 15 ml of water. The aqueous solution was extracted threetimes with 15 ml portions of dichloromethane. The combined extracts weredried over anhydrous sodium sulfate, filtered, and evaporated to affordthe title compound: yield 0.61 g (86%). ¹ H-NMR(CDCl₃): 1.3-2.0 ppm(multiplet, 4H, CH₃ OCHCH₂ CH₂ CH₂ N), 2.6 (singlet, 3H, CH₃ S), 2.8-3.0(multiplet, 4H, COCH₂ CH and NCH₂), 3.3 (broad singlet, 1H, CH₂ CHNCO),3.4 (singlet, 3H CH₃ O), 4.0 (broad doublet, 1H, CHOCH₃), 4.6 (broaddoublet 2H, CH₂ CH═CH₂), 4.8-5.1 (multiple peaks, 2H, NCH₂ CO), 5.2-5.4(multiplet, 2H, CH₂ ═CH), 5.9 (octet, 1H, CH═CH₂), 7.3 (singlet, 1H,aromatic H), 7.9 (singlet, 1H, aromatic H), 7.95 (singlet, 1H, N═CH--N).

EXAMPLE 5trans-7-Bromo-3-[3-(3-methoxypiperid-2-yl)-2-oxopropyl]-6-methylthioquinazolin-4(3H)-oneDihydrobromide

A solution of 0.61 g (0.00116 mol) of the title product of the precedingExample and 30 ml of 33% hydrobromic acid in acetic acid was stirred atroom temperature for 30 minutes. The solution was evaporated underreduced pressure and treated with a few ml of ethanol. The ethanolicsolution was evaporated, and the residue was treated again with ethanol.Again the solution was evaporated. Ethanol was added a final time. Afterstanding overnight at room temperature the solution afforded the presenttitle compound as a crystalline material: m.p. 250°-253° C.; yield 0.11g (16%); mass spectrum m/e 440 (molecular ion +1), 407 (-32, --CH₃ OH),137 (parent peak) amongst others.

EXAMPLE 6trans-7-Bromo-3-[3-(3-hydroxypiperid-2-yl)-2-oxopropyl]-6-methylthioquinazolin-4(3H)-one Dihydrobromide

In a 25 ml round bottom flask, a solution of 0.175 g (0.00029 mol) ofthe title product of the preceding Example and 10 ml of aqueous 48%hydrobromic acid was immersed in an oil bath preheated to 150° C.Heating was continued for 15 minutes. After cooling to nearly roomtemperature, the reaction mixture was evaporated under reduced pressure.The residue was treated with a few ml of ethanol, and the resultingsolution was evaporated. This operation was repeated. Finally theresidue was taken up in 50 ml of hot ethanol, and filtered to removesome insoluble matter. The filtrate was concentrated to about 2 ml.Crystals formed and were filtered to give the instant title compound:yield 0.107 g (63%); high resolution mass spectrum m/e 425.0397(molecular ion with isotope at 427.0416, theory 425.0408). ¹H-NMR(DMSO-d₆) 1.4-2.0 ppm (multiplet, 4H, HOCHCH₂ CH₂ CH₂ N), 2.6(singlet, 3H, SCH₃), 2.8-3.0 (multiplet, 2H, NCH₂), 3.1-3.6 (multiplt,4H, CH₂ N, CHOH, CH₂ CHN), 5.1 (singlet, 2H, NCH₂ CO), 5.6 (doublet, 1H,OH), 7.8 (singlet, 1H, aromatic H), 8.0 (singlet, 1H, aromatic H), 8.2(singlet, 1H, N═CH--N).

EXAMPLE 7 Allyltrans-2-[3-(7-Bromo-6-ethylthioquinazolin-4(3H)-on-3-yl)-2-oxopropyl]-3-methoxy-1-piperidinecarboxylate

In the manner of Example 4, 0.743 g (0.00224 mol) of7-bromo-6-ethylthioquinazolin-4(3H)-one formic acid salt and 0.750 g(0.00224 mol) of allyltrans-2-(3-bromo-2-oxopropyl)-3-methoxy-1-piperidinecarboxylate wereconverted into the title compound. After flash chromatography on silicagel (eluant 3% methanol in chloroform) there was obtained the pureproduct: yield 0.61 g (51%); mass spectrum m/e 537 (molecular ion withexpected isotope pattern), 41 (parent peak, CH₂ ═CH--CH₂ +) amongothers. ¹ H-NMR(CDCl₃) 1.4 ppm (triplet, 3H, SCH₂ CH₃), 1.4-2.1(multiplet, 4H, OCHCH₂ CH₂ CH₂ N), 2.8-3.4 (multiplet, 6H, NCH₂, SCH₂CH₃, COCH₂ CH), 3.4 (singlet, 3H, OCH₃), 4.0 (broad singlet, 1H, CHNCO),4.6 (doublet, 2H, CH₂ CH═CH₂), 5.0 (singlet, 2H, NCH₂ CO), 5.0-5.5(multiplet, 2H, CH═CH₂), 5.6-6.1 (octet, 1H, CH₂ ═CH), 7.3 (singlet, 1H,aromatic H), 7.9 (singlet, 2H, aromatic H, N═CH--N).

EXAMPLE 8trans-7-Bromo-3-[3-(3-methoxypiperid-2-yl)-2-oxopropyl]-6-ethylthioquinazolin-4(3H)-oneDihydrobromide

In the manner of Example 5, 0.61 g (0.00113 mol) of the title product ofthe preceding Example was transformed into present title compound: yield0.316 g (45%); m.p. 225°-228° C.; mass spectrum m/e 454 (molecular ion+H with expected isotope pattern), 421 (-32, --CH₃ OH), 137 (parentpeak) among others. ¹ H-NMR(DMSO-d₆) 1.35 ppm (triplet, 3H, SCH₂ CH₃),1.4-2.2 (multiplet, 4H, OCHCH₂ CH₂ CH₂ N), 2.9-3.1 (multiplet, 2H, CH₂N), 3.1-3.3 (multiplet, 5H, SCH₂ CH₃, COCH₂ CH) 3.3 (singlet, 3H, OCH₃),3.6 (broad singlet, 1H, CH₃ OCH), 5.1 (singlet, 2H, NCH₂ CO), 7.9(singlet, 1H, aromatic H), 8.0 (singlet 1H, aromatic H), 8.2 (singlet,1H, N═CH--N).

EXAMPLE 9trans-7-Bromo-3-[3-(3-hydroxypiperid-2-yl)-2-oxopropyl]-6-ethylthioquinazolin-4(3H)-oneDihydrobromide

In the manner of Example 6, 0.31 g (0.00058 mol) of title product of thepreceding Example was converted to present title compound: yield 0.263 g(87%); mass spectrum m/e 439 (molecular ion with expected isotopepattern), 421 (-18, --H₂ O), 137, 96, 82 (parent peak) among others. ¹H-NMR(DMSO-d₆) 1.35 ppm (triplet, 3H, SCH₂ CH₃), 1.4-2.0 (multiplet, 4H,OCHCH₂ CH₂ CH₂ N), 2.8-3.0 (multipl, 2H, NCH₂), 3.1-3.6 (multiplet, 6H,SCH₂ CH₃, COCH₂ CHCHO), 5.1 (singlet, 2H, NCH₂ CO), 7.9 (singlet, 1H,aromatic H), 8.0 (singlet, 1H, aromatic H), 8.2 (singlet, 1H, N═CH--N).

EXAMPLE 10 Allyltrans-2-[3-(7-Fluoro-6-methylthioquinazolin-4(3H)-on-3-yl)-2-oxopropyl]-3-methoxy-1-piperidinecarboxylate

In the manner of Example 4, 0.462 g (0.0018 mol) of7-fluoro-6-methylthioquinazolin-4(3H)-one formic acid salt and 0.750 g(0.00224 mol) of allyltrans-2-(3-bromo-2-oxopropyl)-3-methoxy-1-piperidinecarboxylate wereconverted into the title compound: yield 0.50 g (60%). ¹ H-NMR(CDCl₃)1.4-2.1 ppm (multiplet, 4H, OCHCH₂ CH₂ CH₂ N), 2.6 (singlet, 3H, SCH₃),2.8-3.4 (multiplet, 4H, NCH₂, COCH₂ CH), 3.4 (singlet 3H, OCH₃), 4.0(broad singlet, 1H, CHNCO), 4.6 (doublet, 2H, CH₂ CH═CH₂), 5.0 (singlet,2H, NCH₂ CO), 5.0-5.5 (multiplet, 2H, CH═CH₂), 5.6-6.1 (octet, 1H, CH₂═CH), 7.3 (doublet, 1H, aromatic H), 7.9 (singlet, 1H, N═CH--N), 8.0(doublet, 1H, aromatic H).

EXAMPLE 11trans-7-Fluoro-3-[3-(3-methoxypiperid-2-yl)-2-oxopropyl]-6-methylthioquinazolin-4(3H)-oneDihydrobromide

In the manner of Example 5, 0.48 g (0.001 mol) of the title product ofthe preceding Example was transformed into the instant title compound:yield 0.324 g (58%); m.p. 214°-216° C.

EXAMpLE 12trans-7-Fluoro-3-[3-(3-hydroxypiperid-2-yl)-2-oxopropyl]-6-methylthioquinazolin-4(3H)-oneDihydrobromide

In the manner of Example 6, 0.32 g (0.00059 mol) of the title product ofthe preceding Example was converted to present title compound: yield0.188 g (60%); mass spectrum m/e 366 (molecular ion +H), 347 (-18, --H₂O), 137 (parent peak) among others. ¹ H-NMR(DMSO-d₆) 1.4-2.1 ppm(multiplet, 4H, OCHCH₂ CH₂ CH₂ N), 2.6 (singlet, 3H, SCH₃), 2.8-3.0(multiplet, 2H, NCH₂), 3.1-3.7 (multiplet, 4H, COCH₂ CHCHO), 5.1(singlet, 2H, NCH₂ CO), 7.5 (doublet, 1H, aromatic H), 7.9 (doublet, 1H,aromatic H), 8.3 (singlet, 1H, N═CH--N), 8.9 (broad singlet, 2H, NH₂).

EXAMPLE 13 Allyltrans-2-[3-(7-Iodo-6-methylthioquinazolrn-4(3H)-on-3-yl)-2-oxopropyl]-3-methoxy-1-piperidinecarboxylate

In the manner of Example 4, 1.09 g (0.003 mol) of7-iodo-6-methylthioquinazolin-4(3H)-one formic acid salt and 1.0 g(0.003 mol) of allyltrans-2-(3-bromo-2-oxo-propyl)-3-methoxy-1-piperidinecarboxylate wereconverted into the title compound: yield 0.53 g (31%); mass spectrum m/e571 (molecular ion), 539 (-32, --CH₃ OH), 221 (parent peak). ¹H-NMR(CDCl₃) 1.4-2.1 ppm (multiplet, 4H, OCHCH₂ CH₂ CH₂ N), 2.6(singlet, 3H, SCH₃), 2.8-3.4 (multiplet, 4H, NCH₂, COCH₂ CH), 3.4(singlet, 3H, OCH₃), 4.0 (broad singlet, 1H, CHNCO), 4.6 (doublet, 2H,CH₂ CH═CH₂), 5.0 (singlet, 2H, NCH₂ CO), 5.0-5.5 (multiplet, 2H,CH═CH₂), 5.6-6.1 (octet, 1H, CH₂ ═CH), 7.7 (singlet, 1H, aromatic H),7.8 (singlet, 1H, N═CH--N), 8.2 (singlet, 1H, aromatic H).

EXAMPLE 14trans-7-Iodo-3-[3-(3-methoxypiperid-2-yl)-2-oxopropyl]-6-methylthioquinazolin-4(3H)-oneDihydrobromide

In the manner of Example 5, 0.53 g (0.00093 mol) of title product of thepreceding Example was transformed into instant title compound: yield0.264 g (44%); m.p. 210°-230° C.; mass spectrum m/e 488 (molecular ion+H+), 469 (-18, --H₂ O?), 455 (-32, --CH₃ OH), 137 (parent peak amongothers. ¹ H-NMR(DMSO-d₆) 1.2-2.0 ppm (multiplet, 4H, OCHCH₂ CH₂ CH₂ N),2.6 (singlet, 3H, SCH₃), 2.8-3.0 (multiplet, 2H, NCH₂), 3.1-3.7(multiplet, 4H, COCH₂ CHCHO), 3.3 (singlet, 3H, OCH₃), 5.1 (singlet, 2H,NCH₂ CO), 7.7 (singlet, 1H, aromatic H), 8.2 (singlet, 1H, aromatic H),8.25 (singlet, 1H, N═CH--N), 8.7 (broad singlet, 2H, NH₂).

EXAMPLE 15trans-7-Iodo-3-[3-(3-hydroxypiperid-2-yl)-2-oxopropyl]-6-methylthioquinazolin-4(3H)-oneDihydrobromide

In the manner of Example 6, 0.262 g (0.0004 mol) of title product of thepreceding Example was converted to the title compound: yield 0.234 g(91%); mass spectrum m/e 473 (molecular ion), 455 (-18, --H₂ O), 318(parent peak) among others. ¹ H-NMR(DMSO-d₆) 1.2-2.0 ppm (multiplet, 4H,OCHCH CH₂ CH₂ N), 2.6 (singlet, 3H, SCH₃), 2.8-3.0 (multiplet, 2H,NCH₂), 3.1-3.6 (multiplet, 4H, COCH₂ CHCHO), 5.1 (singlet, 2H, NCH₂ CO),7.7 (singlet, 1H, aromatic H), 8.2 (singlet, 1H, aromatic H), 8.25(singlet, 1H, N═CH--N), 8.7 (broad singlet, 2H, N₂).

EXAMPLE 16 Allyltrans-2-[3-(6-Chloro-7-methylthioquinazolin-4(3H)-on-3-yl)-2-oxopropyl]-3-methoxy-1-piperidinecarboxylate

In the manner of Example 4, 0.679 g (0.003 mol) of6-chloro-7-methylthioquinazolin-4(3H)-one and 1.0 g (0.003 mol) of allyltrans-2-(3-bromo-2-oxopropyl)-3-methoxy-1-piperidinecarboxylate wereconverted into the title compound: yield 0.56 g (39%). ¹ H-NMR(CDCl₃)1.4-2.2 ppm (multiplet, 4H, OCHCH₂ CH₂ CH₂ N), 2.6 (singlet, 3H, SCH₃),2.8-3.4 (multiplet, 4H, NCH₂, COCH₂ CH), 3.4 (singlet, 3H, OCH₃), 4.0(broad singlet, 1H, CHNCO), 4.6 (doublet, 2H, CH₂ CH═CH₂), 5.0 (singlet,2H, NCH₂ CO), 5.0-5.5 (multiplet, 2H, CH═CH₂), 5.6-6.1 (octet, 1H, CH₂═CH), 7.4 (singlet, 1H, aromatic H), 7.9 (singlet, 1H, N=CH-N), 8.2(singlet, 1H, aromatic H).

EXAMPLE 17trans-6-Chloro-3-[3-(3-methoxypiperid-2-yl)-2-oxopropyl]-7-methylthioquinazolin-4(3H)-oneDihydrobromide

In the manner of Example 5, 0.56 g (0.00118 mol) of title product of thepreceding Example was transformed into the present title compound: yield0.27 g (41%); m.p. 225°-255° C.; mass spectrum m/e 396 (molecularion+H+), 363 (-32, --CH₃ OH), 137 (parent peak) among others; ¹H-NMR(DMSO-d₆) 1.4-1.9 ppm (multiplet, 4H, OCHCH₂ CH₂ CH₂ N), 2.6(singlet, 3H, SCH₃), 2.8-3.0 (multiplet, 2H, NCH₂), 3.1-3.7 (multiplet,4H, COCH₂ CHCHO), 3.3 (singlet, 3H, OCH₃), 5.1 (singlet, 2NCH₂ CO), 7.5(singlet, 1H, aromatic H), 8.1 (singlet, 1H, aromatic H), 8.25 (singlet,1H, N═CH-N), 8.7 (broad singlet, 2H, NH₂).

EXAMPLE 18 trans-6-Chloro-3-[3-(3-hydroxypiperid-2-yl)-2-oxopropyl]-7-methylthioquinazolin-4(3H)-one Dihydrobromide

In the manner of Example 6, 0.26 g (0.000546 mol) of title product ofthe preceding Example was converted to the instant title compound: yield0.104 g (35%); high resolution mass spectrum m/e 363.0835 (molecular ion--18, --H₂ O); ¹ H-NMR(DMSO-d₆) 1.4-2.0 ppm (multiplet, 4H, OCHCH₂ CH₂CH₂ N), 2.6 (singlet, 3H, SCH₃), 2.8-3.0 (multiplet, 2H, NCH₂), 3.1-3.6(multiplet, 4H, COCH₂ CHCHO), 5.1 (singlet, 2H, NCH₂ CO), 7.5 (singlet,1H aromatic H), 8.1 (singlet, 1H, aromatic H), 8.25 (singlet, 1H,N═CH-N), 8.7 (broad singlet, 2H, NH₂).

EXAMPLE 19 Allyl trans-2-[3-(6-Substituted- 7- or8-substituted-quinazolin-4(3H)-on-3-yl)-3-methoxypiperidine-1-carboxylates

By the method of Example 4, equivalent amounts of the appropriatelysubstituted quinazolin-4(3H)-one and allyltrans-2-(3-bromo-2-oxopropyl)-3-methoxy-1-piperidine-1-carboxylate wereconverted to the following title products substituted as follows:

    ______________________________________                                        6-Substituent                                                                              7- or 8-Substituent                                                                        Yield   m.p. (°C.)                           ______________________________________                                        methylthio   none         79      foam.sup.(a)                                ethylthio    none         81      oil.sup.(b)                                 propylthio   none         87      oil.sup.(b)                                 4-bromobenzylthio                                                                          none         68      119-121                                     4-chlorobenzylthio                                                                         7-chloro     49      85-92                                       4-bromobenzylthio                                                                          7-chloro     44      foam.sup.(b)                                4-picolylthio                                                                              7-chloro     42      oil.sup.(b)                                 methylthio   7-methoxy    53      .sup.(c)                                    methylthio   7-chloro     81      oil.sup.(b)                                 ethylthio    7-chloro     78      oil.sup.(b)                                 propylthio   7-chloro     54      .sup.(b)                                    methylthio   7-bromo      86      .sup.(b)                                    methylthio   7-fluoro     60      .sup.(b)                                    methylthio   7-iodo       31      .sup.(b)                                    ethylthio    7-bromo      51      .sup.(b)                                    methylthio   8-chloro     64      oil.sup.(b)                                 methylthio   8-bromo      48      .sup.(b)                                    ethylthio    8-chloro     81      .sup.(b)                                    ethylthio    8-bromo      86      .sup.(b)                                    chloro       8-methylthio 55      128-133                                     chloro       7-methylthio 39      oil.sup.(b)                                 ______________________________________                                         .sup.(a)1 H--NMR(CDCl.sub.3): 1.4-2.1 (m, 4H), 2.6 (s, 3H), 2.8-3.6 (m,       6H), 3.5 (s, 3H), 4.6-6.3 (m, 5H), 5.0 (s, 2H), 7.6-8.1 (m, 4H).              .sup.(b)1 H--NMR consistent with assigned structure, having key features      as in footnote (a).                                                           .sup.(c) tlc Rf 0.82 (9:1 CHCl.sub.3 :CH.sub.3 OH).                      

EXAMPLE 20 Allyltrans-2-[3-(7-Chloro-6-[4-bromobenzylthio]quinazolin-4(3H)-on-3-yl)-2-oxopropyl]-3-hydroxypiperidine-1-carboxylate

A solution of 0.55 g (0.87 mmol) of the 6-(4-bromobenzylthio)-7-chloroproduct of the preceding Example in 20 ml of dichloromethane was cooledto -15° C. under argon. While stirring, 4.4 ml of 1.0M boron tribromidein dichloromethane was added dropwise by syringe. The reaction wasstirred 30 minutes at -15° C., allowed to warm to 20° C., and stirred anadditional 30 minutes. The solution was then poured into 50 ml ofsaturated aqueous sodium bicarbonate. The aqueous phase was extractedfive times with 50 ml portions of dichloromethane. The extracts werecombined with the organic layer, dried over anhydrous magnesium sulfate,and evaporated to yield the title compound as an oil: yield 0.511 g(95%). This material was used without further purification in theprocedure of the next Example.

EXAMPLE 21trans-7-Chloro-3-[3-(3-hydroxypiperid-2-yl)-2-oxopropyl]-6-(4-bromobenzylthio)-quinazolin-4(3H)-oneDihydrochloride

A suspension of 0.50 g (0.8 mmol) of the product from the precedingExample in 25 ml of 6N hydrochloric acid was heated at reflux for 30minutes. The solvent was evaporated and the residue recrystallized fromethanol to afford the title compound as a solid: m.p. 190°-193° C.;yield 137 mg (28%).

EXAMPLE 22 Other Allyltrans-2-[3-(6-Substituted-7-Substituted-quinazolin-4(3H)-on-3-yl)-2-oxopropyl]-3-hydroxypiperidine-1-carboxylates

By the method of Example 20, the appropriately substituted products ofExample 19 were converted to title products substituted as follows:

    ______________________________________                                        6-Substituent 7-Substituent                                                                             Yield   tlc Rf.sup.(a)                              ______________________________________                                        4-chlorobenzylthio                                                                          chloro      67      0.71                                        4-picolylthio chloro      78      0.47                                        methylthio    methoxy     69      0.60                                        ______________________________________                                         .sup.(a) eluant: 9:1 CHCl.sub.3 :CH.sub.3 OH                             

EXAMPLE 23trans-7-Chloro-3-[3-(3-hydroxypiperid-2-yl)-2-oxopropyl]-6-(4-picolylthio)-quinazolin-4(3H)-oneDihydrochloride

By the method of Example 21, the 6-(4-picolylthio)-7-chloro intermediateof the preceding Example was converted to instant title product as afoam in 61% yield; tlc Rf 0.48 (10:2:1 CHCl₃ :ethanol:conc. NH₄ OH).

EXAMPLE 24trans-7-Chloro-3-[3-(3-hydroxypiperid-2-yl)-2-oxopropyl]-6-(4-chlorobenzylthio)-quinazolin-4(3H)-oneDihydrobromide

Using the conditions of Example 3 (refluxing 48% HBr) the6-(4-chlorobenzylthio)-7-chloro product of Example 22 was converted tothe instant title product, m.p. 260°-263° C., in 47% yield.

EXAMPLE 25trans-7-Methoxy-3-[3-(3-hydroxypiperid-2-yl)-2-oxopropyl]-6-methylthioquinazolin-4(3H)-oneDihydrobromide

By heating in 48% HBr at 100° C. for 12 minutes, the6-methylthio-7-methoxy product of Example 22 was converted to theinstant title product, isolated in 69% yield as a foam having ¹H-NMR(DMSO-d₆) 1.4-2.3 (m, 4H), 2.5 (s, 3H), 2.9-3.8 (m, 6H), 4.0 (s,3H), 5.2 (s, 2H), 7.2 (s, 1H), 7.7 (s, 1H), 8.5 (s, 1H).

EXAMPLE 26 Other trans-6-Substituted-7- or8-substituted-3-[3-(3-methoxypiperid-2-yl)-2-oxopropyl]-quinazolin-4(3H)-oneDihydrobromides

By the method of Example 5, other products of Example 19 were convergedto the instant title products substituted as follows:

    ______________________________________                                        6-Substituent                                                                              7- or 8-Substituent                                                                        Yield   m.p. (°C.)                           ______________________________________                                        methylthio   none         43      223-225                                     ethylthio    none         39      203-205                                     propylthio   none         40      .sup.(a)                                    4-bromobenzylthio                                                                          none         38      194-196                                     methylthio   7-chloro     43      234-236                                     ethylthio    7-chloro     34      219-222                                     propylthio   7-chloro     59      212-214                                     methylthio   8-bromo      60      210-214                                     ethylthio    8-chloro     29      211-213                                     ethylthio    8-bromo      48      188-192                                     chloro       7-methylthio 41      225-255                                     chloro       8-methylthio 64      250-253                                     ______________________________________                                         .sup.(a)1 H--NMR(CF.sub.3 CO.sub.2 H) 1.2 (t, 3H), 1.4-2.4 (m, 6H), 3.2       (t, 2H), 3.6 (s, 3H), 5.6 (s, 2H), 7.8-8.4 (m, 4H).                      

EXAMPLE 27 Other trans-6-Substituted-7- or8-substituted-3-[3-(3-hydroxypiperid-2-yl)-2-oxopropyl]-quinazolin-4(3H)-oneDihydrobromides

By the method of Example 6, the products of the preceeding Example areconverted to title products substituted as follows:

    ______________________________________                                        6-Substituent                                                                              7- or 8-Substituent                                                                        Yield   m.p. (°C.)                           ______________________________________                                        methylthio   none         90      foam.sup.(a)                                ethylthio    none         69      193-195                                     propylthio   none         49      203-205                                     4-bromobenzylthio                                                                          none         45      158-160                                     methylthio   7-chloro     78      233-234                                     ethylthio    7-chloro     45      233-234                                     propylthio   7-chloro     70      220-221                                     methylthio   8-bromo      82      224-226                                     ethylthio    8-chloro     84      228-229                                     ethylthio    8-bromo      59      212-214                                     chloro       7-methylthio 35      250-256                                     chloro       8-methylthio 76      228-230                                     ______________________________________                                         .sup.(a)13 C--NMR(DMSOd.sub.6) 14.885, 20.226, 30.766, 39.600, 43.160,        54.657, 56.410, 66.718, 121.074, 121.365, 126.453, 132.807, 138.681,          147.513, 158.840, 200.193.                                               

EXAMPLE 28 Methyltrans-2-[3-(6-Trifluoromethylquinazolin-4(3H)-on-3-yl)-2-oxopropyl]-3-methoxypiperidine-1-carboxylate

By the method of Example 4, 6-trifluoromethylquinazolin-4(3H)-one andmethyl trans-2-(3-bromo-2-oxopropyl)-3-methoxypiperidine-1-carboxylatewere converted into the title compound in 24% yield; m.p. 137°-140° C. ¹H-NMR(CDCl₃) 1.4-1.9 (m, 4H), 2.9 (d, 3.3 (s, 3H), 3.5-3.9 (m, 4H), 3.7(s, 3H), 5.2 (s, 2H), 7.7-8.7 (m, 4H).

EXAMPLE 29 Methyltrans-2-[3-(6-Trifluoromethylquinazolin-4(3H)-on-3-yl)-2-oxopropyl]-3-hydroxypiperidine-1-carboxylate

A 35 ml single neck round bottom flask equipped with a magnetic stirringbar was flame dried and then stoppered with a serum cap. Through asyringe needle the flask was evacuated and filled with dry nitrogen fourtimes. A solution of 0.35 g (0.0008 mol) of title product of thepreceding Example and 10 ml of dichloromethane was injected into thereaction flask, and with stirring the temperature was lowered to -70° C.Again with a syringe 3.0 ml of 1.0M boron tribromide in dichloromethanewas introduced into the reaction vessel. After 10 minutes the reactiontemperature was allowed to rise to -10° C. and was held there for 150minutes. The reaction mixture was then combined with 11 ml of saturatedsodium bicarbonate. The aqueous phase was separated and extracted threetimes with 5 ml portions of dichloromethane. The extracts were combinedwith the original organic layer, dried over anhydrous magnesium sulfate,and evaporated under reduced pressure to furnish the present titlecompound: yield 0.34 g, 100%; ¹ H-NMR(CDCl₃) 1.4-1.9 (m, 4H), 2.9 (d,2H), 3.5-3.9 (m, 4H), 3.7 (s, 3H), 5.2 (s, 2H), 7.7-8.7 (m, 4H).

EXAMPLE 30trans-6-Trifluoromethyl-3-[3-(3-hydroxypiperid-2-yl)-2-oxopropyl]quinazolin-4(3H)-oneDihydrobromide

In a 15 ml single-neck round bottom flask equipped with a refluxcondenser, a solution of 0.27 g (0.0006 mol) of title product of thepreceding Example and 7 ml of 48% aqueous hydrobromic acid was immersedin an oil bath pre-heated to 150° C. Heating was continued for threeminutes. The solution was allowed to cool to room temperature, and thevolatile components were evaporated under reduced pressure. Ethanol (5ml) was added to the residue, and again the mixture was evaporated todryness. This operation was repeated once more to afford a dark residuewhich was then taken up in 3 ml of ethanol, heated at reflux briefly,and cooled to precipitate title product, 0.13 g (39%), m.p. 185°-190° C.

EXAMPLE 31

Allyltrans-2-[3-(6-Cyanoquinazolin-4(3H)-on-3-yl)-2-oxopropyl]-3-methoxypiperidine-1-carboxylate

By the method of Example 4, 6-cyanoquinazolin-4(3H)-one and allyltrans-2-(3-bromo-2-oxopropyl)-3-methoxypiperidine-1-carboxylate wereconverted to title compound in 49% yield; ¹ H-NMR(CDCl₃) 1.2-1.9 (m,4H), 2.9 (d, 2H), 2.9-3.5 (m, 4H), 4.6-6.2 (m, 5H), 5.2 (s, 2H), 7.8-8.6(m, 4H).

EXAMPLE 32 Allyltrans-2-[3-(6-Cyanoquinazolin-4(3H)-on-3-yl)-2-oxopropyl]-3-hydroxypiperidine-1-carboxylate

By the method of Example 20, title product of the preceding Example wasconverted to instant title product in 94% yield; ¹ H-NMR(DMSO-d₆)1.2-1.9 (m, 4H), 2.9-3.8 (m, 6H), 4.5-6.2 (m, 5H), 5.1 (s, 2H), 7.8-8.6(m, 4H).

EXAMPLE 33trans-6-Cyano-3-[3-(3-acetoxypiperid-2-yl)-2-oxopropyl]quinazolin-4(3H)-oneDihydrobromide

1.34 g (0.0032 mol) of title product of the preceding Example wasdissolved in 50 ml of 33% hydrobromic acid in glacial acetic acid at 0°C. and stirred for 30 minutes. The reaction mixture was poured into mlof ether, and the resulting precipitate triturated several additionaltimes with ether, and once with cold acetonitrile to give 880 mg ofcrude product, m.p. 226°-228°. This was recrystallized from ethanol toafford 535 mg (32%) of the title compound, m.p. 227°-229° C.

EXAMPLE 34trans-6-Cyano-3-[3-(3-hydroxypiperid-2-yl)-2-oxopropyl]quinazolin-4(3H)-oneDihydrochloride

Title product of the preceding Example, 0.25 g (0.00047 mol) wasdissolved in 10.0 ml of 6N hydrochloric acid and allowed to stir at roomtemperature for 5 hours or until starting material is no longer detectedby thin layer chromatography. The solvent was then removed at 26°-28° C.under vacuum and the resulting crude solid triturated with acetone togive 179 mg (96%) of the title compound, m.p. 229°-230° C. Analysiscalculated for C₁₇ H₁₈ N₄ O₃.2HCl.1.5H₂ O: C, 47.90; H, 5.44; N, 13.14%.Found: C, 48.00; H, 5.15; N, 12.87%.

PREPARATION 1 4-Chloro-5-(4-chlorophenoxy)-2-nitrobenzoic Acid

To 30 ml of dry diglyme under a nitrogen atmosphere was added 0.960 g(0.02 mol) of sodium hydride dispersion in mineral oil (50%). Thesolution was cooled to 10° C. and 1.28 g (0.01M) 4-chlorophenol in 15 mlof dry diglyme was added dropwise while maintaining the temperature at10° C. This was followed by the dropwise addition of 2.36 g (0.01 mol)of 4,5-dichloro-2-nitrobenzoic acid in 15 ml of dry diglyme. Thereaction mixture was then heated to 153° C. (oil bath) for 1 hour and 45minutes. The reaction mixture was cooled to room temperature and pouredinto an ice/water mixture. The pH was then adjusted to 1.5 with 6Nhydrochloric acid. The solution was extracted with ethyl acetate, andthe organic layer dried over anhydrous magnesium sulfate. The solventwas removed and the crude solid triturated with hexane, followed byrecrystallization from carbon tetrachloride to give the title compound:yield 1.65 g (50%) m.p. 160°-162° C.

By the same method, the following other 2-nitrobenzoic acids wereprepared from the appropriate Y¹ substituted phenol and 5-X¹ substituted2-nitrobenzoic acid:

    ______________________________________                                        Y.sup.1   X.sup.1   m.p. (°C.)                                                                       Yield (%)                                       ______________________________________                                        H         H         149-152   58                                              4-Br      H         153-156   40                                              4-Cl      H         140-148   40                                              3-Cl      H         160-161   31                                              2-Cl      H         105-115   50                                              3,5-diCl  H         195-197   37                                              4-OPh     H         132-134   57                                              4-Br      Cl        208-210   76                                              4-Cl      Cl        160-162   50                                              4-F       F         178-181   50                                              4-Cl      Br        147-150   38                                              3-Cl      Cl        167-169   50                                              3-Br      Cl        168-170   44                                              ______________________________________                                    

PREPARATION 2 2-Amino-4-chloro-5-(4-chlorophenoxy)benzoic Acid

A solution of title product of the preceding Preparation (4.14 g, 0.013mol) in 100 ml of ethanol was hydrogenated at 50 psig over Raney nickel(4.14 g, water moist). After one hour, the reaction mixture was filteredand the mother liquor evaporated under reduced pressure to give 3.37 g(90%) of the title compound, m.p. 160°-170° C. This material was used insubsequent reactions without further purification. By the same method,the other 2-nitrobenzoic acid derivatives of the preceding Preparationwere converted to 2-amino-4-(X¹ substituted)-5-(Y¹ substitutedphenoxy)-benzoic acids as follows:

    ______________________________________                                        Y.sup.1   X.sup.1   m.p. (°C.)                                                                       Yield (%)                                       ______________________________________                                        H         H         142-144   83                                              4-Br      H         159-160   44                                              4-Cl      H         138-148   85                                              3-Cl      H         146-150   80                                              2-Cl      H         foam*     86                                              3,5-diCl  H         180-187   73                                              4-OPh     H         132-134   81                                              4-Br      Cl        208-210   76                                              4-F       Cl        192-193   79                                              4-Cl      Br        194-196   93                                              3-Cl      Cl        174-176   56                                              3-Br      Cl        177-180   81                                              ______________________________________                                         *.sup.1 H--NMR(DMSOd.sub.6) shows multiplet at 6.7-7.8 ppm.              

.spsp.*¹ H-NMR(DMSO-d₆) shows multiplet at 6.7-7.8 ppm.

PREPARATION 3 7-Chloro-6-(4-chlorophenoxy)quinazolin-4(3H)-one [Formula(VI) with X¹ =7-chloro and R¹ 4-chlorophenoxy]

A suspension of 3.3 g (0.011 mol) of title product of the precedingPreparation and 3.04 g (0.068 mol) of formamide was heated at 155° C.(oil bath). Within ten minutes the solid went into solution. After atotal reaction time of 2 hours and 30 minutes, the solution was cooledand poured into water. The crude product was filtered and recrystallizedfrom isopropyl alcohol. Yield 1.91 g (56%); m.p. 250°-252° C.

By the same method other products of the preceding Preparation wereconverted to 7-(X¹ substituted)-6-(Y¹ substitutedphenoxy)quinazolin-4(3H)-ones [of the formula (VI)] as follows:

    ______________________________________                                        Y.sup.1     X.sup.1  m.p. (°C.)                                                                       Yield (%)                                      ______________________________________                                        H           H        196-199   83                                             4-Br        H        219-222   62                                             4-Cl        H        207-211   83                                             3-Cl        H        206-207   85                                             2-Cl        H        190-193   66                                             3,5-diCl    H        237-238   86                                             4-OPh       H        196-197   36                                             4-Br        7-Cl     278-279   43                                             4-F         7-Cl     213-214   35                                             4-Cl        7-Br     267-269   62                                             3-Cl        7-Cl     266-267   43                                             3-Br        7-Cl     258-260   51                                             ______________________________________                                    

PREPARATION 4 5-Bromo-2-methylaniline

A suspension of 300 g (1.39 mol) of 4-bromo-2-nitrotoluene 370 g (9.25mol) of sodium hydroxide, and 4 liters of water was treated with 400 g(3.7 mol) of formamidine sulfinic acid. The mixture was heated underreflux overnight, and then steam distilled. When 16 liters of distillatehad been collected, the distillation was stopped. The distillate wasseparated into aqueous and organic layers. The aqueous layer wasextracted with ethyl acetate three times. The extracts were combinedwith the organic layer, dried over anhydrous sodium sulfate, filtered,and evaporated under reduced pressure to furnish the product as an oil:b.p. 84° C. at 0.075 mmHg; yield 231.1 g (90%). This material has beenprepared previously by reducing the nitro compound with iron [J. Frejkaand F. Vymetal, Coll. Czech. Chem. Commun., 7, 436-443 (1935); C. A. 30,1370 (1936)].

PREPARATION 5 N-(4-Bromo-2-methylphenyl)acetamide

With mechanical stirring and ice-bath cooling, a solution of 231 g (1.24mol) of 5-bromo-2-methylaniline and 250 ml of diethyl ether was treateddropwise with 152.2 g (1.49 mol, 140 ml) of acetic anhydride at such arate as to maintain the reaction temperature below 5° C. The productprecipitated from the reaction mixture and was filtered to givecolorless crystals: yield 215.2 g (76%); m.p. 160°-161° C. [lit. m.p.165° C., Frejka and Vymetal, loc, cit.].

PREPARATION 6 2-Acetylamino-4-bromobenzoic Acid

With mechanical stirring, a suspension of 215 g (0.942 mol) ofN-(4-bromo-2-methyl)acetamide in a solution of 310 g (1.257 mol) ofmagnesium sulfate heptahydrate, 447 g (2.83 mol) of potassiumpermanganate and 10 liters of water was heated under reflux for sixhours during which time the mixture's color changed from clear purple tobrownish-black. Heating was stopped and 50 ml of methanol was added.When at room temperature, the reaction mixture was treated with 250 g ofdiatomaceous earth and 100 g of activated carbon, and was filtered togive a clear colorless solution. The solution was adjusted to pH 4.4 bythe addition of concentrated hydrochloric acid, and the productprecipitated. After filtering and drying the crystals, there wasobtained 171.3 g (70%) of 2-acetylamino-4-bromobenzoic acid: m.p.224°-225° C. [lit. m.p. 220° C., Frejka and Vymetal, loc. cit.].

PREPARATION 7 Ethyl 2-Amino-4-bromobenzoate

A solution of 119 g (0.461 mol) of 2-acetylamino-4-bromobenzoic acid and3 liters of absolute ethanol was cooled to 0° C. and was then saturatedwith a stream of dry hydrogen chloride gas. The solution was then heatedunder reflux for 24 hours. Upon cooling to room temperature, thesolution was evaporated to about 750 ml and then poured into 2 liters ofaqueous saturated sodium bicarbonate. The aqueous phase was extractedthree times with 300 ml portions of chloroform. The combined extractswere dried over anhydrous sodium sulfate, filtered, and evaporated toafford 23.8 g (21%) of ethyl 2-amino-4-bromobenzoate as an oil:ir(CHCl₃) 3504 cm, 3390, 1685, 1610, 1580 among others; ¹ H-NMR(CDCl₃)1.3 ppm (triplet, 3H, CH₂ CH₃), 4.3 (quartet, 2H, CH₂ CH₃), 5.8 (broadsinglet, 2H, NH₂), 6.6 [doublet (part of AB pattern), 1 H, aromatic H],6.8 (singlet, 1H, aromatic H), 7.7 [doublet (part of AB pattern), 1H,aromatic H].

PREPARATION 8 Ethyl 2-Amino-4-bromobenzoate Hydrochloride

At room temperature, a solution of 3.09 g (0.0127 mol) of ethyl2-amino-4-bromobenzoate and 30 ml absolute ethanol was saturated withdry hydrogen chloride gas. A colorless precipitate formed in the warmsolution. When it was again at room temperature, the solution wasdiluted with 30 ml of diethyl ether; the resulting crystalline productwas filtered and washed with diethyl ether. Thus there was obtained 2.72g (77%) of the title compound: m.p. 147°-150° C. Analysis calculated forC₉ H₁₁ BrClNO₂ : C, 38.53; H, 3.95; N, 4.99%. Found: C, 38.48; H; 4.02;N, 4.99%.

PREPARATION 9 Ethyl 2-Amino-4-bromo-5-thiocyanatobenzoate

In a 100 ml three-neck round bottom flask equipped with an internalthermometer and magnetic stirrer, a solution of 3.26 g (0.0116 mol) ofethyl 2-amino-4-bromobenzoate hydrochloride, 2.12 g (0.0279 mol) ofammonium thiocyanate and 30 ml of acetic acid was cooled to 15° C.Bromine (1.86 g, 0.0116 mol) was then added dropwise with stirring. Aprecipitate formed. When the addition was complete, the solution wasallowed to warm to room temperature, and to stir for an hour. Theproduct was filtered, dried under nitrogen, and recrystallized fromhexane and ethyl acetate to furnish crystalline ethyl2-amino-4-bromo-5-thiocyanatobenzoate: yield 2.05 g (59%); m.p.149°-150° C.; ir(KBr) 3487 cm, 3453, 3375, 3346, 2980, 2146, 1697, 1614among others; ¹ H-NMR(CDCl₃) 1.4 ppm (triplet, 3H, CH₂ CH₃), 4.3(quartet, 2H, CH₂ CH₃), 6.0 (broad singlet), 6.9 singlet, 1H, aromaticH), 8.1 (singlet, 1H aromatic H).

PREPARATION 10 Ethyl 2-Amino-4-bromo-5-methylthiobenzoate

Under a nitrogen atmosphere, with ice-bath cooling, and with magneticstirring, 0.134 g (0.00585 mol) of sodium was dissolved in 20 ml ofabsolute ethanol. Ethyl 2-amino-4-bromo-5-thiocyanatobenzoate (0.88 g,0.00292 mol) was added, and when solution was almost complete, themixture was treated with 0.498 g (0.22 ml, 0.0035 mol) of methyl iodide.The solution was allowed to warm to room temperature, and to stirovernight. After pouring the reaction mixture into 200 ml of ice water,the resulting aqueous solution was adjusted to pH 6.5 by the addition of2N hydrochloric acid. The aqueous solution was then extracted threetimes with 30 ml portions of ethyl acetate. The combined extracts weredried over anhydrous sodium sulfate, filtered, and evaporated to furnishthe crude product: yield 0.88 g. This material was chromatographed undermoderate pressure on a column of silica gel (i.d. 3.5 cm×height 17.5cm); the eluant was 10% ethyl acetate/90% hexanes. Fractions of 20 mleach were collected. Fractions 27-38 gave crystals of the titlecompound: yield 0.66 g (78%); m.p. 48°-50° C.; ir(KBr) 3461 cm, 3354,2976, 2914, 1680, 1603 among others; mass spectrum 289 (parent peak andmolecular ion with expected isotope pattern), 274 (-15, --CH₃), 261 (-28--CH₂ CH₂), 243 (-46, --CH₃ CH₂ OH) among others; ¹ H-NMR(CDCl₃) 1.3 ppm(triplet, 3H, CH₂ CH₃), 2.4 (singlet, 3H, SCH₃), 4.3 (quartet, 2H, CH₂CH₃), 5.8 (broad singlet, 2H, NH₂), 6.9 (singlet, 1H, aromatic H), 7.9(singlet, 1H, aromatic H).

Analysis calculated for C₁₀ H₁₂ BrNO₂ S: C, 41.39; H, 4.17; N, 4.83%.Found: C, 41.44; H, 4.14; N, 4.54%.

PREPARATION 11 7-Bromo-6-methylthioquinazolin-4(3H)-one Formic Acid Salt

In a flame dried 50 ml round bottom flask equipped with a magneticstirrer and under a nitrogen atmosphere, a solution of 1.01 g (0.62 ml,0.00659 mol) of phosphorous oxychloride and 5 ml of drydimethylformamide was cooled to 0° C. In another 5 ml ofdimethylformamide, 1.6 g (0.00552 mol) of ethyl2-amino-4-bromo-5-methylthiobenzoate was added to the reaction flask.The solution was stirred for an hour at 0° C., and then 11 ml ofconcentrated ammonium hydroxide was added. The reaction mixture wasallowed to come to room temperature, and was stirred overnight. Afterbeing poured into 30 ml of water, the reaction mixture was filtered, andthe product was dried under nitrogen. It was then recrystallized fromhot formic acid to furnish colorless crystals of the title compound:yield 1.33 g (76%); m.p. 272°-274° C.; mass spectrum 270 (parent peakand molecular ion with expected isotope pattern), 255 (-15, --CH₃) amongothers.

Analysis calculated for C₁₀ H₉ BrN₂ O₃ S: C, 37.87; H, 2.86; N, 8.83%.Found: C, 38.06; H, 2.97; N, 8.79%.

PREPARATION 12 Ethyl 2-Amino-4-bromo-5-ethylthiobenzoate

In the manner of Preparation 10, 2.5 g (0.0083 mol) of ethyl2-amino-4-bromo-5-thiocyanatobenzoate and 1.55 g (0.010 mol) of ethyliodide were converted into the title compound: yield 1.78 g (70%); ir(neat) 3472 cm⁻¹, 3360, 2971, 2921, 2863, 1691, 1604, 1569, 1542 amongothers; mass spectrum peaks m/e 305 (parent peak, higher isotope), 303(molecular ion) among others; ¹ H-NMR(CDCl₃) 1.4 ppm ["quartet"(overlapping triplets, 6H, SCH₂ CH₃, OCH₂ CH₃ ], 2.3 (quartet, 2H, SCH₂CH₃), 4.4 (quartet, 2H, OCH₂ CH₃), 5.9 (broad singlet, 2H, NH₂), 7.0(singlet, 1H, aromatic H), 8.0 (singlet, 1H, aromatic H).

PREPARATION 13 7-Bromo-6-ethylthioquinazolin-4(3H)-one Formic Acid Salt

In the manner of Preparation 11, 1.78 g (0.00585 mol) of ethyl2-amino-4-bromo-5-ethylthiobenzoate was transformed into the titlecompound: yield 1.22 g (63%); m.p. 272°-273° C.; mass spectrum m/e 286(parent peak), 284 (molecular ion), 269 (-15, --CH₃), 256 (-28, --CO),177 (-28, -79, --CO, --Br) among others.

Analysis calculated for C₁₁ H₁₁ BrN₂ O₃ S: C, 39.89; H, 3.35; Br, 24.13;N, 8.46; S, 9.68%. Found: C, 39.60; H, 3.20; Br, 25.40; N, 8.61; S,9.94%.

PREPARATION 14 N-(4-Fluoro-2-methylphenyl)acetamide

In the manner of Preparation 5, 20 g (0.160 mol) of5-fluoro-2-methylaniline was converted into the title compound: yield25.0 g (94%); m.p. 131°-132° C., [lit. m.p. 133.5°-134° C.: E. A. Steck,L. T. Fletcher, J. Am. Chem. Soc. 70, 439-440 (1948)].

PREPARATION 15 2-Acetylamino-4-fluorobenzoic Acid

In the manner of Preparation 6, 12.5 g (0.075 mol) ofN-(4-fluoro-2-methylphenyl)acetamide was transformed into the titlecompound: yield 11.88 g (81%); m.p. 212.5°-214.5° C., [lit. m.p.209°-209.5° C.: Steck and Fletcher loc. cit.].

PREPARATION 16 Ethyl 2-Amino-4-fluorobenzoate

In the manner of Preparation 7, 30.79 g (0.156 mol) of2-acetylamino-4-fluorobenzoic acid was converted into the titlecompound: yield 20.43 g (71%); ir (neat) 3482 cm, 3367, 2933, 2903,2871, 1692, 1627, 1593, 1573, 1500; ¹ H-NMR(CDCl₃) 1.3 ppm (triplet, 3H,OCH₂ CH₃), 4.3 (quartet, 2H, OCH₂ CH₃), 5.8 (broad singlet, 2H, NH₂),6.2-6.6 (multiplet, 2H, aromatic H), 7.2-8.0 (multiplet, 1H, aromaticH).

PREPARATION 17 Ethyl 2-Amino-4-fluorobenzoate Hydrochloride

In the manner of Preparation 8, 20.43 g (0.112 mol) of ethyl2-amino-4-fluorobenzoate was transformed into its hydrochloride salt:yield 19.35 g (79%); licorice odor; m.p. 153°-156° C.; mass spectrum m/e183 (molecular ion), 155 (-28, --CO), 138 (-45, --CH₃ CH₂ O), 137(parent peak, -46, --CH₃ CH₂ OH), 110 (-73, --CO₂ CH₂ CH₃) among others;¹ H-NMR(DMSO-d₆) 1.3 ppm (triplet, 3H, OCH₂ CH₃), 4.2 (quartet, 2H, OCH₂CH₃), 6.3 (doublet of triplets, 1H, aromatic H), 6.6 (doublet ofdoublets, 1H, aromatic H), 7.8 (doublet of doublets, 1H, aromatic H),8.2 (broad singlet, 2H, NH₂).

Analysis calculated for C₉ H₁₁ ClFNO₂ : C, 49.21; H, 5.05; Cl, 16.14; F,8.65; N, 6.38%. Found: C, 49.45; H, 4.89; Cl, 15.77; F, 8.63; N, 6.39%.

PREPARATION 18 Ethyl 2-Amino-4-fluoro-5-thiocyanatobenzoate

In the manner of Preparation 9, 15.22 g (0.0695 mol) of ethyl2-amino-4-fluorobenzoate hydrochloride was used to prepare the titlecompound. The yield after "flash" chromatography (on silica gel; eluanthexanes:chloroform 6:4) was 2.36 g (14%): m.p. 144°-145° C.; ir(KBr)cm⁻¹ 3453, 3341, 2979, 2932, 2899, 2141, 1698, 1625, 1591, 1552 amongothers; mass spectrum m/e 240 (molecular ion), 212 (-28, --CO), 194(parent peak, -46, --CH₃ CH₂ OH) among others.

Analysis calculated for C₁₀ H₉ FN₂ O₂ S: C, 50.00; H, 3.75; N, 11.67; S,13.33%. Found: C, 49.79; H, 3.78; N, 11.25; S, 13.09%.

PREPARATION 19 Ethyl 2-Amino-4-fluoro-5-methylthiobenzoate

In the manner of Preparation 10, 2.34 g (0.0097 mol) of ethyl2-amino-4-fluoro-5-thiocyanatobenzoate was transformed into the titlecompound: yield 2.46 g (100%, some solvent included); ir(KBr) 3481 cm,3367, 2980, 2917, 1688, 1620, 1582, 1556 among others; mass spectrum m/e229 (molecular ion), 214 (-15, --CH₃), 201 (-28, --CO), 183 (parentpeak, -46, --CH₃ CH₂ OH) among others; ¹ H-NMR(CDCl₃) 1.3 ppm (triplet,3H, OCH₂ CH₃), 2.3 (singlet, 3H, SCH₃), 4.2 (quartet, 2H, OCH₂ CH₃), 6.0(broad singlet, 2H, NH₂), 6.3 (doublet, 1H, aromatic H), 7.9 (doublet,1H, aromatic H).

PREPARATION 20 7-Fluoro-6-methylthioquinazolin-4(3H)-one Formic AcidSalt

In the manner of Preparation 11, 2.46 g (0.0107 mol) of ethyl2-amino-4-fluoro-5-methylthiobenzoate was converted into the titlecompound: yield 0.83 g (30%); mass spectrum m/e 210 (molecular ion andparent peak), 195 (-15, --CH₃) among others; ¹ H-NMR(DMSO-d₆) 2.6 ppm(singlet, 3H, SCH₃), 7.4 (doublet, 1H, aromatic H), 7.9 (doublet, 1H,aromatic H), 8.0 (singlet, 1H, N═CH--N), 8.1 (singlet, 1H, HCO₂ H).

Analysis calculated for C₁₀ H₉ FN₂ O₃ S: C, 46.87; H, 3.54; N, 10.93; S,12.51%. Found: C, 47.58; H, 3.38; N, 11.45; S, 13.67%.

PREPARATION 21 N-(4-Iodo-2-methylphenyl)acetamide

In the manner of Preparation 5, 10 g (0.043 mol) of5-iodo-2-methylaniline was converted into the title compound: yield 11.1g (94%); m.p. 182°-183° C.

Analysis calculated for C₉ H₁₀ INO: C, 39.29; H, 3.66; N, 5.09%. Found:C, 39.61; H, 3.77; N, 4.96%.

PREPARATION 22 2-Acetylamino-4-iodobenzoic Acid

In the manner of Preparation 6, 10 g (0.036 mol) ofN-(4-iodo-2-methylphenyl)acetamide was transformed into the titlecompound: yield 4.66 g (42%); m.p. 229°-232° C.

Analysis calculated for C₉ H₈ INO₃ : C, 35.43; H, 2.64; I, 41.60, N,4.59%. Found: C, 35.28; H, 2.66; I, 41.19; N, 4.51%.

PREPARATION 23 Ethyl 2-Amino-4-iodobenzoate

In the manner of Preparation 7, 31.22 g (0.102 mol) of2-acetylamino-4-iodobenzoic acid was converted into the title compound:yield 17.65 g (59%); m.p. 51°-53° C.; ir (neat) 3475 cm, 3363, 2974,2927, 2896, 1689, 1603, 1578, 1543; mass spectrum m/e 291 (molecular ionand parent peak), 245 (-46, --CH₃ CH₂ OH) among others; ¹ H-NMR(CDCl₃)1.3 ppm (triplet, 3H, OCH₂ CH₃), 4.3 (quartet, 2H, OCH₂ CH₃), 5.7 (broadsinglet 2H, NH₂), 6.9 (doublet, 1H, aromatic H), 7.0 (singlet, 1H,aromatic H), 7.5 (doublet, 1H, aromatic H).

Analysis calculated for C₉ H₁₀ INO₂ : C, 37.13; H, 3.46; I, 43.60; N,4.81%. Found: C, 36.83; H, 3.35; I, 43.12; N, 5.52%.

PREPARATION 24 Ethyl 2-Amino-4-iodobenzoate Hydrochloride

In the manner of Preparation 8, 18.75 g (0.0644 mol) of ethyl2-amino-4-iodobenzoate was transformed into its hydrochloride salt:yield 19.20 g (91%); m.p. 147°-149° C.; mass spectrum m/e 291 (molecularion and parent peak), 245 (-46, --CH₃ CH₂ OH) among others; ¹H-NMR(DMSO-d₆) 1.3 ppm (triplet, 3H, OCH₂ CH₃), 4.2 (quartet, 2H, OCH₂CH₃), 6.9 (doublet of doublets, 1H, aromatic H), 7.3 doublet, 1H,aromatic H), 7.4 (doublet, 1H, aromatic H), 7.8 (broad singlet, 2H,NH₂).

Analysis calculated for C₉ H₁₁ ClINO₂ : C, 33.00; H, 3.39; I, 38.74; N,4.28%. Found: C, 33.01; H, 3.36; I, 37.36; N, 4.24%.

PREPARATION 25 Ethyl 2-Amino-4-iodo-5-thiocyanatobenzoate

In the manner of Preparation 9, 17.05 g (0.052 mol) of ethyl2-amino-4-iodobenzoate hydrochloride was used to prepare the titlecompound. The yield after flash chromatography (on silica gel; eluanthexanes: chloroform 6:4) was 10.3 g (57%): m.p. 164°-165.5° C.; ir(KBr)cm⁻¹ 3449, 3345, 2966, 2920, 2142, 1693, 1613, 1566, 1534 among others;mass spectrum m/e 348 (molecular ion and parent peak), 320 (-28, --CO),302 (-46, --CH₃ CH₂ OH) among others; ¹ H-NMR(CDCl₃) 1.3 ppm (triplet,3H, OCH₂ CH₃), 4.2 (quartet, 2H, OCH₂ CH₃), 5.8 (broad singlet, 2H,NH₂), 7.2 (singlet, 1H, aromatic H), 8.2 (singlet, 1H, aromatic H).

Analysis calculated for C₁₀ H₉ IN₂ O₂ S: C, 34.50; H, 2.61; I, 36.45; N,8.05; S, 9.21%. Found: C, 33.94; H, 2.54; I, 35.20; N, 7.74; S, 10.54%.

PREPARATION 26 Ethyl 2-Amino-4-iodo-5-(methylthio)benzoate

In the manner of Preparation 10, 3.0 g (0.0086 mol) of ethyl2-amino-4-iodo-5-thiocyanatobenzoate was transformed into the titlecompound: yield 1.79 g (62%); m.p. 59°-60° C.; ir(KBr) 3414 cm, 3311,2980, 2906, 1690, 1607, 1568, 1549 among others; mass spectrum m/e 337(molecular ion and parent peak), 322 (-15, --CH₃), 309 (-28, --CO), 291(-46, --CH₃ CH₂ OH) among others; ¹ H-NMR (CDCl₃) 1.4 ppm (triplet, 3H,OCH₂ CH₃), 2.4 (singlet, 3H, SCH₃), 4.3 (quartet, 2H, OCH₂ CH₃), 5.7(broad singlet, 2H, NH₂), 7.2 (singlet, 1H, aromatic H), 7.8 (singlet,1H, aromatic H).

Analysis calculated for C₁₀ H₁₂ INO₂ S: C, 35.61; H, 3.56; N, 4.15%.Found: C, 35.80; H, 3.63; N, 4.08%.

PREPARATION 27 7-Iodo-6-methylthioquinazolin-4(3H)-one Formic Acid Salt

In the manner of Preparation 11, 2.5 g (0.0074 mol) of ethyl2-amino-4-iodo-5-methylthiobenzoate was converted into the titlecompound: yield 1.23 g (46%); m.p. 268°-270° C.; mass spectrum m/e 318(molecular ion and parent peak) among others; ¹ H-NMR(DMSO-d₆) 2.6 ppm(singlet, 3H, SCH₃), 7.6 (singlet, 1H, aromatic H), 8.0 (singlet, 1H,aromatic H), 8.05 (singlet, 1H, N═CH--N), 8.1 (singlet, 1H, HCO₂ H).

Analysis calculated for C₁₀ H₉ IN₂ O₃ S: C, 32.97; H, 2.47; N, 7.69%.Found: C, 33.14; H, 2.68; N, 7.81%.

PREPARATION 28 6-Chloro-7-methylthioquinazolin-4(3H)-one

Under a nitrogen atmosphere in a flame dried flask equipped with amagnetic stirrer and a reflux condenser, a mixture of 1.00 g (0.00465mol) of 6,7-dichloroquinazolin-4(3H)-one and 18 ml of dimethylformamidewas treated at room temperature with 0.56 g (0.012 mol) of 50% sodiumhydride in mineral oil. Foaming began immediately and most of the solidsdissolved. When the foaming had subsided, 1.8 ml (0.0176 mol) of 47%methyl mercaptan in dimethyl formamide was added to the stirred mixture.The mixture was heated at 120° C. for six hours. When the reactionmixture was again at room temperature, a small amount of insolublematter was filtered, and was rinsed with a few ml of dimethylformamide.The filtrate was washed three times with 10 ml portions of hexane. Thefiltrate was then poured into 300 ml of ice and water. By the additionof 2N hydrochloric acid, the aqueous solution was adjusted to pH 2.There formed a fine colorless precipitate which was filtered, washedwith water, air dried and pressed on a clay plate to furnish the titlecompound: yield 0.97 g (92%); m.p. 292°-295° C. (dec.); mass spectrumm/e 226 (parent peak and molecular ion with expected isotope pattern),193 (-33) among others; ¹ H-NMR(DMSO-d₆) 2.6 ppm (singlet, 3H, SCH₃),7.45 (singlet, 1H, aromatic H), 8.0 (singlet, 1H, aromatic H), 8.15(singlet, 1H, N═CH--N).

PREPARATION 29 2-Amino-5-(ethylthio)benzoic Acid

To a 500 ml flask fitted with a magnetic stirrer, dropping funnel andthermometer, and containing a solution of 12.7 g (0.192 mol) of 85%potassium hydroxide in 300 ml of methanol was added in portions 10.0 g(0.0481 mol) of methyl 2-amino-5-thiocyanatobenzoate. The solution wascooled to 10° C. and a solution of 6.29 g (0.058 mol) ethylbromide in 50ml of methanol was added over 10 minutes. This was followed by theaddition of 8.0 g (0.048 mol) potassium iodide. After 2.5 hours, thereaction mixture was evaporated to a semi-solid under reduced pressureand treated with 300 ml of water. The aqueous solution was extractedwith chloroform, and the organic layer dried over magnesium sulfate. Thesolution was filtered and evaporated to give 7.5 g (79%) of crudeproduct. This material was recrystallized from hexane to give 3.01 g(32%) of the title compound, m.p. 97°-100° C.

PREPARATION 30 2-Amino-5-(propylthio)benzoic Acid

To a solution containing 50 ml of water, 25 ml of methanol and 6 ml of1N sodium hydroxide was added 0.88 g (0.0037 mol) of ethyl2-amino-5-propylthiobenzoate. The reaction was heated at reflux for 1hour, cooled to room temperature, concentrated to a white solid andtreated with 200 ml of water. The solution was then acidified with 6Nhydrochloric acid and the resulting white precipitate filtered and driedto afford 0.54 g (70%) of the title compound, m.p. 91°-93° C.

PREPARATION 31 2-Amino-5-(methylthio)benzoic Acid

By the method of Preparation 2, 2-nitro-5-(methylthio)benzoic acid[Tilley et al., Org. Prep. Proced. 13, pp 189-196 (1984)] was convertedto instant title product in 70% yield, m.p. 148°-150° C.

PREPARATION 32 Other Thiocyanato-2-aminobenzoate Esters

By the method of Preparations 9, 18 and 25, ethyl 2-aminobenzoate andappropriately 3- or 4-substituted ethyl 2-aminobenzoates were convertedto the following ethyl 2-amino-5-thiocyanatobenzoates:

    ______________________________________                                        Further Substituents                                                                            Yield   m.p. (°C.)                                   ______________________________________                                        None              44      104-106                                             4-chloro          45      151-153                                             3-chloro          69      76-78                                               3-bromo           63        63-65.5                                           4-methoxy         63      106-108                                             ______________________________________                                    

By the same method, methyl 2-aminobenzoate was converted to methyl2-amino-5-thiocyanatobenzoate (m.p. 110°-112° C.) in 69% yield.

By the same method, ethyl 2-amino-5-chlorobenzoate was converted toethyl 2-amino-5-chloro-3-thiocyanatobenzoate (m.p. 128°-130° C.) in 8%yield.

PREPARATION 33 Other Alkylthio-2-aminobenzoate Esters and RelatedCompounds

By the method of Preparations 10, 19 and 26, substituting an equivalentamount of the appropriate alkyl, benzyl or picolyl halide for methyliodide, the following ethyl 5-substituted-3- or4-substituted-2-aminobenzoates were prepared from the products of thepreceding Example:

    ______________________________________                                        Substituents        Yield   m.p. (°C.)                                 ______________________________________                                        5-methylthio        82      34-36                                             5-ethylthio         84      51-53                                             5-propylthio        83      oil.sup.(a)                                       5-(4-bromobenzylthio)                                                                             68      oil.sup.(b)                                       5-(4-chlorobenzylthio)-4-chloro                                                                   52      82-85                                             5-(4-bromobenzylthio)-4-chloro                                                                    100     72-81                                             5-(4-picolylthio)-4-chloro                                                                        93      102-107                                           5-methylthio-4-methoxy                                                                            61      92-94                                             5-methylthio-4-chloro                                                                             82      50.5-53.5                                         5-ethylthio-4-chloro                                                                              100     oil.sup.(c)                                       5-propylthio-4-chloro                                                                             99      oil.sup.(d)                                       5-ethylthio-4-bromo 70      oil.sup.(e)                                       5-methylthio-3-chloro                                                                             100     oil.sup.(f)                                       5-methylthio-3-bromo                                                                              77      oil.sup.(g)                                       5-ethylthio-3-chloro                                                                              .sup.(h)                                                                              --                                                5-ethylthio-3-bromo 91      oil.sup.(i)                                       5-methylthio-5-chloro                                                                             20      oil.sup.(j)                                       ______________________________________                                         .sup.(a) m/e 239.0980 (molecular ion).                                        .sup.(b)1 H--NMR(CDCl.sub.3) 1.3 (t, 3H), 3.8 (s, 2H), 4.2 (q, 2H), 6.4       (d, 1H), 7.1 (m, 5H), 7.7 (d, 1H).                                            .sup.(c) m/e 259/261 (chlorine isotope).                                      .sup.(d)1 H--NMR(CDCl.sub.3) 1.4 (m, 8H), 2.8 (t, 2H), 4.2 (q, 2H), 6.8       (s, 1H), 8.0 (s, 1H).                                                         .sup.(e) m/e 303/305 (molecular ion, chlorine isotope).                       .sup.(f) m/e 245/247 (molecular ion, chlorine isotope).                       .sup.(g) m/e 289/291 (molecular ion, bromine isotope).                        .sup.(h) hydrolyzed in next step without characterization; overall yield      35%.                                                                          .sup.(i) correctly analyses for C.sub.11 H.sub.14 O.sub.2 NSBr.               .sup.(j) m/e 245.0366 (molecular ion).                                   

PREPARATION 34 Other Alkylthio-2-aminobenzoic Acids

By the method of Preparation 30, appropriate products of the precedingExample were hydrolyzed to yield the following3-substituted-5-substituted-2-amino-benzoic acids:

    ______________________________________                                        3-Substituent                                                                           5-Substituent                                                                             Yield    m.p. (°C.)                              ______________________________________                                        chloro    methylthio  57       157-162                                        bromo     methylthio  75       159-162                                        chloro    ethylthio     35.sup.(a)                                                                           133-135                                        bromo     ethylthio   77       121.5-123.5                                    methylthio                                                                              chloro      80       156-159                                        ______________________________________                                         .sup.(a) yield over 2steps                                               

PREPARATION 35 Other Alkylthioquinazolin-4(3H)-ones

By the method of Preparation 3, 2-aminobenzoic acids of precedingPreparations 30, 31 and 35 were converted to the following substitutedquinazolin-4(3H)-ones:

    ______________________________________                                        Substituents      Yield   m.p. (°C.)                                   ______________________________________                                        6-methylthio      72      200-202                                             6-ethylthio       66      166-169                                             6-propylthio      62      151-154                                             6-methylthio-8-chloro                                                                           63      257-263                                             6-methylthio-8-bromo                                                                            65      275-280                                             6-ethylthio-8-chloro                                                                            77      267-270                                             6-chloro-8-methylthio                                                                           59      324-327                                             ______________________________________                                    

PREPARATION 36 Other Substituted Quinazolin-4(3H)-ones Formic Acid Salts

By the method of Preparations 11, 13, 20 and 27, appropriatelysubstituted ethyl 2-aminobenzoates of Preparation 34 were converted tothe following substituted quinazolin-4(3H)-ones:

    ______________________________________                                        Substituents        Yield   m.p. (°C.)                                 ______________________________________                                        6-(4-bromobenzylthio)                                                                             74      209-212                                           6-(4-chlorobenzylthio)-7-chloro                                                                   69      245-248                                           6-(4-bromobenzylthio)-7-bromo                                                                     51      265-268                                           6-(4-picolylthio)-7-chloro                                                                        45      196-207                                           6-methylthio-7-methoxy                                                                            50      292-294                                           6-methylthio-7-chloro                                                                             58      270-274                                           6-ethylthio-7-chloro                                                                              54      238-241                                           6-propylthio-7-chloro                                                                             48      202-205                                           ______________________________________                                    

PREPARATION 37 4-Trifluoromethyl-N-pivaloylaniline

To a solution of 6.87 g (0.043 mol) of 4-trifluoromethylaniline in 110ml of dichloromethane was added 5.25 ml (0.043 mol) of pivaloylchloride.After stirring for 1.5 hours, 190 ml of a saturated solution of aqueoussodium bicarbonate was added. The reaction proceeded an additional 2hours and the organic layer was separated and dried over anhydrousmagnesium sulfate. The solution was filtered and the solvent removed togive the title compound, yield 9.16 g (88%), m.p. 154°-158° C.

PREPARATION 38 2-(N-Pivaloyl)-5-trifluoromethylbenzoic Acid

A solution of 25.0 g (0.102 mol) of 4-trifluoromethyl-N-pivaloylanilinein 140 ml of dry tetrahydrofuran was cooled to 5° C. under a nitrogenatmosphere. This was followed by the dropwise addition of 110 ml (0.22mol) of 2.0M n-butyllithium in hexane. The addition was carried out over2 hours while maintaining the temperature below 15° C. When the additionwas complete, the temperature was raised to 20° C. and the reactionstirred for 7 hours. The solution was then cooled to -60° C. and drycarbon dioxide gas was bubbled through the reaction at a rapid rate for15 minutes, during which time the thick suspension was diluted with anadditional 150 ml of dry tetrahydrofuran. After stirring for 16 hours,the reaction mixture was treated with 100 ml of saturated aqueousammonium chloride. The reaction mixture was then concentrated to 150 mland diluted with 1.0 liter of water. The pH was adjusted to 1.0 withhydrochloric acid, and the resulting solution extracted with ethylacetate. The organic layer was dried over magnesium sulfate, filteredand evaporated under reduced pressure to afford the crude product. Thiswas recrystallized from toluene to give 7.8 g (26%) of the titlecompound, m.p. 196°-198° C.

PREPARATION 39 Methyl 2-Amino-5-trifluoromethylbenzoate

A solution of 7.46 g (0.026 mol) of2-(N-pivaloyl)-5-trifluoromethylbenzoic acid in 300 ml of methanol wascooled to 5° C. and saturated with gaseous hydrochloric acid. Thereaction mixture was then heated at reflux for 20 hours, and evaporatedto a solid. The crude solid was dissolved in chloroform and washed withsaturated aqueous sodium bicarbonate. The organic layer was dried andevaporated to a viscous oil, which was purified by silica gelchromatography (9:1 hexane:ethylacetate). The title compound wasisolated as a white solid, m.p. 51°-52° C.; yield 4.0 g (71%).

PREPARATION 40 6-Trifluoromethylquinazolin-4(3H)-one

By the method of Preparation 11, title product of the precedingPreparation was converted to instant title product in 71% yield, m.p.209°-211° C.

Analysis calculated for C₉ H₅ N₂ OF₃ : C, 50.47; H, 2.34, N, 13.08%.Found: C, 49.81; H, 2.28; N, 12.98%.

PREPARATION 41 6-Cyanoquinazolin-4(3H)-one

6-Aminoquinazolin-4(3H)-one was slurried in 300 ml of 5% hydrochloricacid and the reaction mixture was cooled to 5° C. A solution of 6.72 g(0.097 mol) of sodium nitrite in 30 ml of water was added dropwise over2.5 hours while maintaining the reaction temperature below 10° C. Theresulting diazonium salt was then added portionwise to a hot (86° C.)solution of 7.84 g (0.0876 mol) of copper cyanide and 11.0 g (0.224 mol)sodium cyanide in 60 ml of water. Evolution of nitrogen was evidentthroughout the addition. After stirring for 30 minutes, the reactionmixture was filtered, washed with water, and air-dried. The crudeproduct (9.1 g) was purified by silica gel chromatography to afford 3.89g (26%) of the title compound; m.p. 294°-300° C.

I claim:
 1. A compound having the formula ##STR11## wherein X is fluoro,chloro, bromo or iodo substituted at the 6- or 7-position;R is (C₁ -C₄)alkylthio; X¹ is hydrogen or fluoro, chloro, bromo, iodo or methoxysubstituted either at the 7- or at the 8-position; and R¹ is cyano,trifluoromethyl, (C₁ -C₄) alkylthio, 4-picolylthio, 3,5-dichlorophenoxy,##STR12## where Y¹ is hydrogen, fluoro, chloro, bromo or phenoxy; and Y²is chloro or bromo; with the proviso that Y¹ is other than hydrogen whenX¹ is other than hydrogen,or a pharmaceutically-acceptable acid additionsalt thereof.
 2. A compound of claim 1 having the formula (I).
 3. Thecompound of claim 2 wherein R is methylthio and X is 6-chloro.
 4. Thecompound of claim 2 wherein R is methylthio and X is 7-chloro.
 5. Acompound of claim 1 having the formula (II).
 6. A compound of claim 5wherein R¹ is cyano.
 7. The compound of claim 6 wherein X¹ is hydrogen.8. A compound of claim 5 wherein R¹ is trifluoromethyl.
 9. The compoundof claim 8 wherein X¹ is hydrogen.
 10. A compound of claim 5 wherein R¹is (C₁ -C₄)alkylthio.
 11. A compound of claim 10 wherein X¹ is hydrogen.12. The compound of claim 11 wherein R¹ is methylthio.
 13. The compoundof claim 11 wherein R¹ is ethylthio.
 14. The compound of claim 11wherein R¹ is propylthio.
 15. A compound of claim 10 wherein R¹ ismethylthio.
 16. The compound of claim 15 wherein X¹ is 7-chloro.
 17. Thecompound of claim 15 wherein X¹ is 7-bromo.
 18. The compound of claim 15wherein X¹ is 7-fluoro.
 19. The compound of claim 15 wherein X¹ ishydrogen.
 20. The compound of claim 15 wherein X¹ is 8-chloro.
 21. Acompound of claim 5 wherein R¹ is ##STR13##
 22. The compound of claim 21wherein X¹ is hydrogen and Y¹ is 4-chloro.
 23. A compound of claim 21wherein X¹ is 7-chloro.
 24. The compound of claim 23 wherein Y¹ is4-chloro.
 25. The compound of claim 23 wherein Y¹ is 4-bromo.
 26. Thecompound of claim 23 wherein Y¹ is 4-fluoro.
 27. A compound of claim 5wherein R¹ is ##STR14##
 28. The compound of claim 27 wherein X¹ ishydrogen and Y² is 4-bromo.
 29. The compound of claim 28 wherein X¹ is7-chloro and Y² is 4-chloro.
 30. A method of controlling or preventingcoccidiosis in poultry which comprises administering to said poultry ananticoccidially effective amount of a compound of claim 1 in drinkingwater or in nutritionally-balanced feed.
 31. A method of controlling ofpreventing coccidiosis in poultry which comprises administering to saidpoultry an anticoccidially effective amount of a compound of claim 2 indrinking water or in nutritionally-balanced feed.
 32. A method ofcontrolling or preventing coccidiosis in poultry which comprisesadministering to said poultry an anticoccidially effective amount of acompound of claim 5 in drinking water or in nutritionally-balanced feed.33. A method of controlling or preventing coccidiosis in poultry whichcomprises administering to said poultry an anticoccidially effectiveamount of a compound of claim 6 in drinking water or innutritionally-balanced feed.
 34. A method of controlling or preventingcoccidiosis in poultry which comprises administering to said poultry ananticoccidially effective amount of a compound of claim 10 in drinkingwater or in nutritionally-balanced feed.
 35. A method of controlling orpreventing coccidiosis in poultry which comprises administering to saidpoultry an anticoccidially effective amount of a compound of claim 21 indrinking water or in nutritionally-balanced feed.
 36. A method ofcontrolling or preventing coccidiosis in poultry which comprisesadministering to said poultry an anticoccidially effective amount of acompound of claim 27 in drinking water or in nutritionally-balancedfeed.
 37. A composition comprising an anticoccidial effective amount ofa compound of claim 1 and an inert carrier which is suitable for use asa premix or concentrate in the preparation of medicated water or feedfor poultry.